HOME › DRUGS › ALBIGLUTIDE
ACTIVE SUBSTANCE / INN

ALBIGLUTIDE

Brand name(s): TANZEUM, Eperzan
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
Diabetes Mellitus, Type 2
BLA125431
ACTIVE SUBSTANCE
Albiglutide
REGULATORS
FDA · EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited, GLAXOSMITHKLINE LLC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TANZEUMBLA125431GLAXOSMITHKLINE LLCDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EperzanGlaxoSmithKline Trading Services LimitedWithdrawn20/03/2014Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ALBIGLUTIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →